- Record: found
- Abstract: found
- Article: not found
Pazopanib.
2009-12-31
Antineoplastic Agents, adverse effects, pharmacology, therapeutic use, Carcinoma, Renal Cell, drug therapy, physiopathology, Clinical Trials as Topic, Drug Delivery Systems, Humans, Kidney Neoplasms, Protein Kinase Inhibitors, Pyrimidines, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors, Sulfonamides
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Related collections
Author and article information
Antineoplastic Agents,adverse effects,pharmacology,therapeutic use,Carcinoma, Renal Cell,drug therapy,physiopathology,Clinical Trials as Topic,Drug Delivery Systems,Humans,Kidney Neoplasms,Protein Kinase Inhibitors,Pyrimidines,Receptors, Vascular Endothelial Growth Factor,antagonists & inhibitors,Sulfonamides
Antineoplastic Agents, adverse effects, pharmacology, therapeutic use, Carcinoma, Renal Cell, drug therapy, physiopathology, Clinical Trials as Topic, Drug Delivery Systems, Humans, Kidney Neoplasms, Protein Kinase Inhibitors, Pyrimidines, Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors, Sulfonamides